Biotech Scan
Scan
Biotech Scan
raw scan snapshot — prices as of scan date, not live 31 rows · screens, not recommendations superseded by2026-04-26-biotech-scanported fromresearch/classic/scans/_archive/2026-04-03-biotech-scan.mdscan slugbiotech-scansource typescan-archive
Biotech split: large-cap pharma (PFE, MRK, JNJ) near highs while NVO collapses -55% from peak. Gene editing rallying off lows (EDIT +159% 1Y). MRNA monster run cooling off.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🟡 Mixed — pharma defensives strong, growth biotech under pressure |
| Leaders | PFE (RSI 62, near 52wk high), MRK (+27.2% vs SMA200), JNJ (+23.6% vs SMA200) |
| Laggards | NVO (-27.6% vs SMA200), LEGN (-32.9%), BMRN (-42.9% 3Y) |
Price Table
| Stock | Price | RSI | vs SMA20 | 7D% | 30D% | 3M% | Trend | Signal |
|---|---|---|---|---|---|---|---|---|
| ABBV | $208.84 | 40.2 | -3.1% | -1.43% | -10.70% | -4.39% | down | 🔍 Watch |
| GILD | $139.71 | 47.5 | -0.9% | +1.93% | -4.96% | +18.77% | weak-down | 🔍 Watch |
| AMGN | $347.94 | 40.0 | -2.9% | -1.36% | -7.71% | +9.24% | weak-down | 🔍 Watch |
| REGN | $761.85 | 50.9 | +0.9% | +1.39% | -0.63% | -0.06% | weak-down | 🔍 Watch |
| BIIB | $177.34 | 40.7 | -4.1% | -5.22% | -3.63% | +1.55% | weak-down | 🔍 Watch |
| LLY | $935.58 | 46.4 | -0.6% | +5.41% | -7.16% | -10.02% | weak-down | 🔍 Watch |
| VRTX | $438.71 | 40.4 | -4.3% | -1.58% | -7.50% | -2.25% | weak-down | 🔍 Watch |
| NVO | $36.98 | 45.4 | +1.8% | +2.27% | +4.58% | -30.44% | strong-down | 🔍 Research |
| BNTX | $91.18 | 46.2 | +1.0% | +5.39% | -9.51% | -5.85% | strong-down | 🔍 Watch |
| MRNA | $49.20 | 46.5 | -5.9% | -4.54% | -1.26% | +52.94% | strong-up | 🔒 Hold |
| ALNY | $318.85 | 46.8 | 0.0% | -1.98% | +0.06% | -19.85% | strong-down | 🔍 Watch |
| BMRN | $55.50 | 43.3 | -2.4% | +1.20% | -5.18% | -5.72% | down | 🔍 Watch |
| INCY | $95.93 | 53.7 | +3.0% | +4.75% | -2.18% | -5.76% | weak-down | 🔍 Watch |
| CRSP | $49.51 | 49.3 | +1.1% | +5.99% | -14.73% | -10.23% | strong-down | 🔍 Watch |
| BEAM | $24.66 | 47.7 | -0.6% | +7.40% | -9.40% | -8.12% | weak-down | 🔍 Watch |
| EDIT | $2.67 | 64.3 | +10.9% | +18.58% | +30.88% | +34.17% | up | 🔍 Watch |
| NTLA | $13.13 | 51.7 | +0.6% | +2.02% | -3.46% | +40.13% | weak-down | 🔍 Watch |
| LEGN | $19.14 | 57.2 | +4.4% | +10.06% | +7.17% | -5.76% | weak-up | 🔍 Watch |
| PFE | $28.32 | 61.9 | +3.8% | +3.02% | +6.55% | +14.38% | strong-up | 🔒 Hold |
| MRK | $120.87 | 61.7 | +3.4% | +1.12% | +1.61% | +13.33% | strong-up | 🔒 Hold |
| JNJ | $243.04 | 57.7 | +1.1% | +0.27% | -1.50% | +19.59% | strong-up | 🔒 Hold |
Entry Zones
| Stock | Entry Zone | RSI | Thesis |
|---|---|---|---|
| NVO | <$40 | 45.4 | GLP-1 leader, -55% from high, watch for bottom |
| ABBV | <$210 | 40.2 | Dividend king, approaching oversold |
| VRTX | <$440 | 40.4 | CF franchise strong, -14% from high |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| 🔒 HOLD | PFE, MRK, JNJ, MRNA | Pharma defensives + MRNA momentum |
| 🔍 RESEARCH | NVO, ABBV, VRTX | Quality names nearing entry zones |
| 🔍 WATCH | LLY, GILD, REGN, AMGN | Mid-range, no urgency |
| ⚠️ AVOID | EDIT, LEGN | Speculative names, high risk |
Related
10 eventsNo direct external sources are attached to this read.